In yesterday’s Wall Street session, Cassava Sciences Inc (NASDAQ:SAVA) shares traded at $2.75, up 16.53% from the previous session.
SAVA stock price is now -80.86% away from the 50-day moving average and -86.56% away from the 200-day moving average. The market capitalization of the company currently stands at $132.30M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On October 08, 2024, H.C. Wainwright Upgraded its previous ‘Neutral’ rating to ‘Buy’ on the stock keeping its target price maintained at $116, while ‘B. Riley Securities’ rates the stock as ‘Neutral’
In other news, Kupiec James William, Chief Medical Officer sold 4,000 shares of the company’s stock on Nov 29 ’24. The stock was sold for $15,480 at an average price of $3.87. Upon completion of the transaction, the Chief Medical Officer now directly owns 0 shares in the company, valued at $0.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 29 ’24, Chief Financial Officer Schoen Eric sold 59,800 shares of the business’s stock. A total of $230,828 was realized by selling the stock at an average price of $3.86. This leaves the insider owning 11,500 shares of the company worth $31625.0. A total of 13.11% of the company’s stock is owned by insiders.
During the past 12 months, Cassava Sciences Inc has had a low of $2.23 and a high of $42.20. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 3.55, and a quick ratio of 3.55. The fifty day moving average price for SAVA is $14.366 and a two-hundred day moving average price translates $20.46825 for the stock.
The latest earnings results from Cassava Sciences Inc (NASDAQ: SAVA) was released for 2024-09-30.
